Host immunity to commensal gut fungi
宿主对共生肠道真菌的免疫力
基本信息
- 批准号:9598612
- 负责人:
- 金额:$ 47.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Bacterial AgentsAntibioticsAntifungal AgentsAwarenessBacteriaCandidaCandida albicansCardiovascular DiseasesCellsColitisDefectDevelopmentDiabetes MellitusDietDiseaseExtrinsic asthmaFatty acid glycerol estersGenesGeneticGrowthHealthHigh Fat DietHomeostasisHumanImmuneImmune responseImmune systemImmunityInflammatoryInflammatory Bowel DiseasesInflammatory ResponseIntestinesLinkLung diseasesMeasuresMediatingMicrobeModelingMucosal ImmunityMusOralPatientsPopulationPredispositionRecombinant DNAResistanceRoleSaccharomycesSaccharomyces cerevisiaeSaccharomycetalesSeveritiesTissuesVariantbacteriomecommensal bacteriadysbiosisfungal microbiotafungusgut microbiotaimmune functionin vivomembermicrobiotamouse modelmycobiomerepaired
项目摘要
SUMMARY/ABSTRACT
Little is known about the role of gut fungi in regulating a healthy gut microflora and in contributing to
inflammatory disorders. Most studies of gut microflora focus on commensal bacteria which make up the majority
of microbes in the gut. Numerous studies have documented effects of intestinal bacteria on tuning mucosal
immunity and in instructing tissue development and repair. Antibiotic use, host genetics, and diet influence the
bacterial microbiota and susceptibility to intestinal inflammatory disease. What about fungi? Our overall
hypothesis is that intestinal fungal dysbiosis influences the immune system in ways that can increase
susceptibility to inflammatory disease and that can be targeted to increase resistance to inflammatory disease.
In this renewal proposal, we document that disruption of the “normal” mycobiome in mice causes increased
susceptibility to colitis and to allergic asthma. We propose studies aimed at understanding how antibiotic use,
host genetics, and diet influence the intestinal fungal microbiota (“mycobiota”) in the near and long-term. We
will characterize how common (Candida and Saccharomyces) and less well-known (Wallemia, Epicoccum)
fungi influence susceptibility to intestinal inflammatory disease.
总结/摘要
关于肠道真菌在调节健康肠道微生物区系和促进肠道微生物生长方面的作用,
炎症性疾病大多数肠道菌群的研究集中在肠道细菌,占大多数
肠道中的微生物许多研究已经证明了肠道细菌对调节粘膜的影响,
免疫和指导组织发育和修复。抗生素使用、宿主遗传学和饮食影响
细菌微生物群和对肠道炎性疾病的易感性。真菌呢我们的整体
一种假说是肠道真菌生态失调影响免疫系统,
其可被靶向以增加对炎性疾病的抗性。
在这项更新提案中,我们记录了小鼠中“正常”真菌生物群的破坏导致增加的
易患结肠炎和过敏性哮喘。我们建议进行旨在了解抗生素使用,
宿主遗传学和饮食在近期和长期影响肠道真菌微生物群(“真菌生物群”)。我们
将描述常见(念珠菌属和酵母菌属)和不太知名(瓦耳菌属、Epicoccum)
真菌影响对肠道炎性疾病的易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Underhill其他文献
Peptidoglycan recognition by the innate immune system
先天免疫系统对肽聚糖的识别
- DOI:
10.1038/nri.2017.136 - 发表时间:
2018-01-02 - 期刊:
- 影响因子:60.900
- 作者:
Andrea J. Wolf;David M. Underhill - 通讯作者:
David M. Underhill
PD19-01 EVALUATION OF THE VAGINAL MYCOBIOME IN ASYMPTOMATIC PRE-MENOPAUSAL WOMEN
- DOI:
10.1016/j.juro.2018.02.991 - 发表时间:
2018-04-01 - 期刊:
- 影响因子:
- 作者:
Victoria Scott;Jie Tang;Tiina Drell;Jaak Simm;Andres Salumets;Madis Metsis;David M. Underhill;A. Lenore Ackerman - 通讯作者:
A. Lenore Ackerman
Non-protective immune imprint underlies failure of emStaphylococcus aureus/em IsdB vaccine
金黄色葡萄球菌 IsdB 疫苗失败的基础是非保护性免疫印记
- DOI:
10.1016/j.chom.2022.06.006 - 发表时间:
2022-08-10 - 期刊:
- 影响因子:18.700
- 作者:
Chih-Ming Tsai;J.R. Caldera;Irshad A. Hajam;Austin W.T. Chiang;Chih-Hsiung Tsai;Haining Li;María Lázaro Díez;Cesia Gonzalez;Desmond Trieu;Gislâine A. Martins;David M. Underhill;Moshe Arditi;Nathan E. Lewis;George Y. Liu - 通讯作者:
George Y. Liu
David M. Underhill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Underhill', 18)}}的其他基金
Non-Toll-like receptor innate immune signaling
非 Toll 样受体先天免疫信号传导
- 批准号:
7540386 - 财政年份:2008
- 资助金额:
$ 47.68万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 47.68万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 47.68万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 47.68万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 47.68万 - 项目类别:
Studentship